Dr Manjit Kaur

Allergy
Dermatology
Dermatological surgery
Hair and nail disease
Inflammatory skin disease
Paediatric dermatology
Photodermatology
Skin cancer

Special clinical interests: Hair and scalp disorders, photodermatoses (light-induced skin problems) and phototherapy, skin cancer, photodynamic therapy, inflammatory skin disease including acne, eczema, psoriasis, allergy and use of botulinum toxin for axillary hyperhidrosis/aesthetics.

BMedSci (Hons) / University of Nottingham / 1998
Bachelor of medical science
Degree awarded for basic science research.

BMBS / University of Nottingham / 2000
Bachelor of Medicine Bachelor of Surgery
Degree given to junior doctors after completion of 5 years medical degree.

MRCP / Royal College of Physicians of London / 2003
Membership to Royal College of Physicians
Awarded by merit to postgraduate doctors in training.

PGCMedEd / University of Wolverhampton / 2008
Post Graduate Certificate of Medical Education
Teaching qualification.

CCT (Dermatology) / West Midlands Deanery for training / 2008
Certificate of Completion of Training
Qualification awarded for completion of higher specialist training in Dermatology.

FRCP / Royal College of Physicians of London / 2016
Fellowship of Royal College of Physicians
Awarded by merit to senior specialist doctors.

---

Professional memberships

Royal College of Physicians

British Medical Association

British Association of Dermatologists

British Hair and Nail Society

General Medical Council

Medical Protection Society

---

Professional leadership

I am lead for the photodynamic therapy service at Good Hope Hospital. I am lead for the hair service and topical immunotherapy service at University Hospitals NHS Foundation Trust.

I enjoy contributing new knowledge to my field, and I am an author on more than 25 publications in peer-reviewed journals and more than 40 published abstracts presented at national and international scientific congresses.

I have more than 25 peer-reviewed publications including: 

• Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
  Tziotzios C, Petridis C, Dand N, Ainali C, Saklatvala JR, Pullabhatla V, Onoufriadis A, Pramanik R, Baudry D, Lee SH, Wood K, Liu L, Seegobin S, Michelotti GA, Lwin SM, Christou EAA, Curtis CJ, de Rinaldis E, Saxena A, Holmes S, Harries M, Palamaras I, Cunningham F, Parkins G, Kaur M, Farrant P, McDonagh A, Messenger A, Jones J, Jolliffe V, Ali I, Ardern-Jones M, Mitchell C, Burrows N, Atkar R, Banfield C, Alexandroff A, Champagne C, Cooper HL, Vañó-Galván S, Molina-Ruiz AM, Perez NO, Patel GK, Macbeth A, Page M, Bryden A, Mowbray M, Wahie S, Armstrong K, Cooke N, Goodfield M, Man I, de Berker D, Dunnill G, Takwale A, Rao A, Siah TW, Sinclair R, Wade MS, Dlova NC, Setterfield J, Lewis F, Bhargava K, Kirkpatrick N, Estivill X, Stefanato CM, Flohr C, Spector T, Watt FM, Smith CH, Barker JN, Fenton DA, Simpson MA, McGrath JA.
  Nat Commun. 2019 Mar 8;10(1):1150.
• Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens.
  Debroy Kidambi A, Dobson K, Holmes S, Carauna D, Del Marmol V, Vujovic A, Kaur MR, Takwale A, Farrant P, Champagne C, Harries M, Messenger AG.
  Br J Dermatol. 2017 Jul;177(1):260-261.
• Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents.
  Mansouri Y, Martin-Clavijo A, Newsome P, Kaur MR.
  Br J Dermatol. 2016 Apr;174(4):916-8.
• Diphenylcyclopropenone for alopecia areata: a U.K. survey.
  Karanovic S, Harries M, Kaur MR.
  Br J Dermatol. 2018 Aug;179(2):514-515.
• Retrospective review of 18 British South Asian women with frontal fibrosing alopecia.
  Petrof G, Cuell A, Rajkomar VV, Harries MJ, Takwale A, Holmes S, Cunningham F, Kaur MR.
  Int J Dermatol. 2018 Apr;57(4):490-491.
• Congenital desmoplastic trichoepithelioma.
  Carter JJ, Kaur MR, Hargitai B, Brown R, Slator R, Abdullah A.
  Clin Exp Dermatol. 2007 Sep;32(5):522-4.
• The 'golden goddess' of spices: a potentially effective topical therapy for Bowen disease?
  Harper N, Saigal H, Kaur MR, Orpin S.
  Clin Exp Dermatol. 2017 Jul;42(5):545-547. doi: 10.1111/ced.13099. Epub 2017 May 17.
• Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp.
  Fremlin GA, Orpin S, Kaur MR.
  Clin Exp Dermatol. 2017 Dec;42(8):913-914.
• Persistent hypereosinophilia with Wells syndrome.
  Powell J, Salim A, Muc R, Colloby P, Kaur MR.
  Clin Exp Dermatol. 2013 Jan;38(1):40-3.
• Severe recalcitrant pyoderma gangrenosum treated with infliximab.
  Kaur MR, Lewis HM.
  Br J Dermatol. 2005 Sep;153(3):689-91.
• Familial progressive hyper- and hypopigmentation and malignancy in two families with new mutations in KITLG.
  Cuell A, Bansal N, Cole T, Kaur MR, Lee J, Loffeld A, Moss C, O'Donnell M, Takeichi T, Thind CK, McGrath JA.
  Clin Exp Dermatol. 2015 Dec;40(8):860-4.
• An unexpected growth arising within nevus sebaceous of Jadassohn.
  Chan SA, Hejmadi R, Webster K, Kaur MR.
  Dermatol Online J. 2016 Jan 15;22(1):13030
• Two cases of nicorandil-induced ulceration mimicking skin malignancy.
  Sharma A, Orpin S, Goulding JM, Kaur MR.
  Br J Dermatol. 2014 Sep;171(3):662-3. PMID: 24836355 No abstract available.
• 2011-2012 survey and audit of phototherapy services in the West Midlands, UK.
  Powell JB, Kaur MR.
  Clin Exp Dermatol. 2014 Jan;39(1):65-6.
• Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin.
  Raghavendran RR, Humphreys F, Kaur MR.
  Clin Exp Dermatol. 2014 Jan;39(1):68-9.
• Oral terbinafine as an alternative treatment for Hailey-Hailey disease.
  Lew TT, Kaur MR, Hague JS.
  Clin Exp Dermatol. 2013 Dec;38(8):929-30.
• An unusual adverse effect of long-term corticosteroid use.
  Kaur MR, Suortamo S, Wong L, Gach JE.
  Clin Exp Dermatol. 2011 Jun;36(4):424-6.
• Two cases of pustular toxic epidermal necrolysis.
  Hague JS, Kaur MR, Hafiji J, Carr RA, Lewis H, Charles-Holmes R, Heagerty A, Orpin SD.
  Clin Exp Dermatol. 2011 Jan;36(1):42-5.
• A longstanding nail abnormality in a young man.
  Kaur MR, Sethi B, Roberts C, Titley G, Lim SP.
  Clin Exp Dermatol. 2009 Mar;34(2):273-4.
• Disseminated clustered juvenile xanthogranuloma: an unusual morphological variant of a common condition.
  Kaur MR, Brundler MA, Stevenson O, Moss C.
  Clin Exp Dermatol. 2008 Aug;33(5):575-7.
• Delayed diagnosis of leprosy due to presentation with a rheumatoid-like polyarthropathy.
  Kaur MR, Grindulis K, Maheshwari M, Ellis CJ, Bhat J, Tan CY.
  Clin Exp Dermatol. 2007 Nov;32(6):784-5.
• Humoral hypercalcaemia of malignancy associated with primary cutaneous squamous cell carcinoma.
  Kaur MR, Marsden JR, Nelson HM.
  Clin Exp Dermatol. 2007 Mar;32(2):237-8.
• Melanoma histopathology reporting: are we complying with the National Minimum Dataset?
  Kaur MR, Colloby PS, Martin-Clavijo A, Marsden JR.
  J Clin Pathol. 2007 Oct;60(10):1121-3.
• Neutrophilic dermatosis of the dorsal hands treated with indomethacin.
  Kaur MR, Bazza MA, Ryatt KS.
  Br J Dermatol. 2006 Nov;155(5):1089-90.
• Hidradenitis suppurativa treated with dapsone: A case series of five patients.
  Kaur MR, Lewis HM.
  J Dermatolog Treat. 2006;17(4):211-3.
• Recurrent postoperative pyoderma gangrenosum complicating pacemaker insertion.
  Kaur MR, Gach JE, Marshall H, Lewis HM.
  J Eur Acad Dermatol Venereol. 2006 Apr;20(4):466-7.
• Granulocytic sarcoma (leukaemia cutis) in association with basal cell carcinoma.
  Youssef AH, Zanetto U, Kaur MR, Chan SY.
  Br J Dermatol. 2006 Jan;154(1):201-2.

---

Articles

“It has changed my attitudes completely and I am making sure my sun-loving friends are also made aware of the dangers"
May 2016

Be skincare aware in the sun!
May 2016

May is Melanoma Awareness Month
May 2017

University Hospitals Birmingham NHS Foundation Trust (Solihull and Goodhope Hospitals).

In my spare time, I enjoy fine dining/cooking, travelling, keeping fit and spending time with family and friends.

Telephone	0121 580 7119
Private secretary	Claire Thompson
Private secretary telephone	0121 580 7328
Private secretary fax	0121 352 1971
Private secretary email	Claire.Thompson@spirehealthcare.com